Retention rates of infliximab and tocilizumab during a 3-year period in a Brazilian hospitalOriginal Article Published on 2013-01-012024-09-02 Journal: Einstein [Category] 대상포진, [키워드] antibodies Arthritis Biological agents monoclonal/therapeutic use rheumatoid/drug therapy [DOI] 10.1590/S1679-45082013000400015 PMC 바로가기 [Article Type] Original Article